Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
43 studies found for:    Open Studies | "Testicular Neoplasms"
Show Display Options
Rank Status Study
21 Unknown  High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy
Conditions: Brain and Central Nervous System Tumors;   Extragonadal Germ Cell Tumor;   Testicular Germ Cell Tumor
Interventions: Biological: filgrastim;   Biological: pegfilgrastim;   Drug: carboplatin;   Drug: cisplatin;   Drug: dexamethasone;   Drug: etoposide;   Drug: ifosfamide;   Other: high-dose chemotherapy with autologous stem cell rescue;   Other: laboratory biomarker analysis;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: peripheral blood stem cell transplantation
22 Recruiting Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant
Conditions: Cancer Survivor;   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms;   Neuroblastoma;   Testicular Germ Cell Tumor
Interventions: Genetic: DNA analysis;   Genetic: polymerase chain reaction;   Other: flow cytometry;   Other: laboratory biomarker analysis
23 Unknown  Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors
Conditions: Extragonadal Germ Cell Tumor;   Teratoma;   Testicular Germ Cell Tumor
Interventions: Biological: bleomycin sulfate;   Drug: cisplatin;   Drug: etoposide;   Drug: ifosfamide;   Drug: oxaliplatin;   Drug: paclitaxel
24 Unknown  Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor Progression
Conditions: Childhood Germ Cell Tumor;   Extragonadal Germ Cell Tumor;   Ovarian Cancer;   Testicular Germ Cell Tumor
Interventions: Genetic: DNA methylation analysis;   Genetic: mutation analysis;   Genetic: nucleic acid sequencing;   Genetic: polymerase chain reaction;   Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Other: medical chart review
25 Recruiting Magnetic Resonance Imaging and Computed Tomography in Patients With Stage I Seminoma of the Testicle
Condition: Testicular Germ Cell Tumor
Interventions: Other: questionnaire administration;   Procedure: computed tomography;   Procedure: magnetic resonance imaging;   Procedure: quality-of-life assessment
26 Not yet recruiting A Case-control Study to Assess the Association Between Environmental, Domestic and Occupational Exposures to Pesticides and the Risk of Testicular Germ Cell Tumor
Condition: Testicular Germ Cell Tumor
Intervention: Other: Phone interview and blood test
27 Recruiting Toxicity Attributed to Genetic Polymorphisms in Testicular Germ Cell Tumor Survivors
Condition: Germ Cell Cancer
Intervention:
28 Not yet recruiting Decitabine and Vaccine Therapy for Patients With Relapsed AML Following Allogeneic Stem Cell Transplantation
Condition: Acute Myelogenous Leukemia
Intervention: Biological: Vaccine
29 Recruiting Phase I/II Study to Assess the Safety and Activity of Enhanced TCR Transduced Autologous T Cells in Metastatic Melanoma
Condition: Melanoma
Intervention: Biological: NY-ESO-1
30 Unknown  Peptide Vaccination in Treating Patients With Esophageal Cancer
Condition: Esophageal Cancer
Intervention: Biological: TTK, LY6K, and IMP-3 peptides
31 Unknown  A Study With Peptide Vaccination in Treating Patients With Esophageal Cancer
Condition: Esophageal Cancer
Intervention: Biological: peptide
32 Unknown  Peptide Vaccination in Treating Patients With Esophageal Cancer (STF-II)
Condition: Esophageal Cancer
Intervention: Biological: vaccination
33 Recruiting DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study
Conditions: Pleuropulmonary Blastoma;   Cystic Nephroma;   Ovarian Sertoli-Leydig Cell Tumors;   Ocular Medulloepithelioma;   Nasal Chondromesenchymal Hamartoma
Intervention:
34 Recruiting Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome
Conditions: Pleuropulmonary Blastoma;   Cystic Nephroma;   Sertoli-Leydig Cell Tumor of Ovary;   Medulloepithelioma;   Embryonal Rhabdomyosarcoma of Cervix
Intervention:
35 Recruiting Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors
Conditions: Childhood Germ Cell Tumor;   Ovarian Cancer;   Teratoma
Interventions: Drug: carboplatin;   Drug: etoposide;   Drug: ifosfamide;   Drug: paclitaxel;   Drug: thiotepa;   Procedure: autologous hematopoietic stem cell transplantation;   Drug: Mesna;   Biological: filgrastim
36 Unknown  Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer
Condition: Cancer
Interventions: Genetic: DNA analysis;   Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Other: medical chart review;   Other: questionnaire administration;   Procedure: assessment of therapy complications;   Procedure: evaluation of cancer risk factors
37 Recruiting Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant
Condition: Cancer
Interventions: Biological: anti-thymocyte globulin;   Biological: rituximab;   Drug: clofarabine;   Procedure: stem cell transplantation
38 Recruiting Brentuximab Vedotin (SGN-35) as Salvage Treatment for CD30-positive Germ Cell Tumors
Condition: Germ Cell Cancer
Intervention: Drug: Brentuximab Vedotin
39 Not yet recruiting CC-486 (Oral Azacitidine) Bioequivalence Study in Patients With Solid Tumor or Hematologic Malignancies
Conditions: Hematological Neoplasms;   Non-Hodgkin's Lymphoma;   Hodgkin's Lymphoma;   Lymphoma;   Multiple Myeloma;   Acute Myeloid Leukemia;   Leukemia;   Myelodysplastic Syndromes;   Neoplasms;   Melanoma;   Breast Cancer;   Metastatic Breast Cancer;   Non-Small Cell Lung Cancer;   Small Cell Lung Cancer;   Renal Cell Carcinoma;   Glioblastoma Multiforme;   Osteosarcoma;   Sarcoma;   Thyroid Cancer;   Genitourinary
Interventions: Drug: CC-486;   Drug: Vidaza
40 Not yet recruiting Pazopanib in Advanced and Cisplatin-resistant Germ Cell Tumors
Conditions: Germ Cell Tumors;   Measurable Disease;   Relapse or Progression After 2 or 3 Chemotherapy Regimens.;   Relapse or Progression After High-dose Chemotherapy.
Intervention: Drug: Pazopanib

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-43) Show next page of results    Last Page
Indicates status has not been verified in more than two years